Product pipeline
A healthy pipeline points to a promising future
The Celsion pipeline of proven chemotherapeutics enhanced with LTSL includes docetaxel (in preclinical development) and platinum (in formulation development).
In the future, Celsion intends to apply various lipid and focused-heat technologies in order to provide more effective, better targeting, concentrated cancer therapies.
Use in proven chemotherapeutics lowers development risk while accelerating approval and time to market. Because LTSL is being introduced in established treatments, clinical programs will be less complex, and the approval process and time to market streamlined.